GENE ANALYSIS OF PLATELET-Naka ANTIGEN EXPRESSION ON MONOCYTES IN PLATELET-Naka- SUBJECTS

We have already demonstrated that Naka antigen (GPIV) is expressed on the monocytes in platelet-Naka- subjects. To define the molecular basis for the discrepancies of GPIV expression between monocytes and platelets in Naka- subjects, we studied whether there are differences in monocyte GPIV mRNA obt...

Full description

Saved in:
Bibliographic Details
Published inJournal of the Japan Society of Blood Transfusion Vol. 37; no. 6; pp. 817 - 821
Main Authors Furubayashi, Takayasu, Imai, Yumiko, Yonezawa, Takeshi, Kurata, Yoshiyuki, Honda, Shigenori, Kashiwagi, Hirokazu, Tomiyama, Yoshiaki, Mizutani, Hajime, Take, Hironori
Format Journal Article
LanguageJapanese
Published The Japan Society of Transfusion Medicine and Cell Therapy 1991
Online AccessGet full text
ISSN0546-1448
1883-8383
DOI10.3925/jjtc1958.37.817

Cover

More Information
Summary:We have already demonstrated that Naka antigen (GPIV) is expressed on the monocytes in platelet-Naka- subjects. To define the molecular basis for the discrepancies of GPIV expression between monocytes and platelets in Naka- subjects, we studied whether there are differences in monocyte GPIV mRNA obtained from Naka- and Naka+ subjects, and compared these monocyte GPIV mRNA with Naka- platelet GPIV mRNA which we have recently reported. In Northern blot analysis, monocyte GPIV mRNA from two platelet-Naka- subjects exhibited the same size of 2.9kb and nearly the same amounts as that from platelet-Naka+ subject. And restriction enzyme analysis of GPIV cDNAs which were amplified by a reverse transcription polymerase chain reaction (RT-PCR) showed predictable fragment length. We have already shown that RT-PCR analysis of GPIV mRNA from both Naka- and Naka+ platelets and restriction enzyme analysis of these PCR products show no apparent differences between them. Thus, we conclude that GPIV mRNA from both monocytes and platelets in Naka- subjects has no apparent abnormalities and seems to be the same as that in Naka+ subjects.
ISSN:0546-1448
1883-8383
DOI:10.3925/jjtc1958.37.817